UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

The Lancet (British edition), 2010-04, Vol.375 (9722), p.1278-1286

2010

Volltextzugriff (PDF)

PRION-1 scales analysis supports use of functional outcome measures in prion disease

Neurology, 2011-11, Vol.77 (18), p.1674-1683

2011

Volltextzugriff (PDF)

Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998

Thorax, 2001-03, Vol.56 (3), p.173-179

2001

Volltextzugriff (PDF)

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

The Lancet (British edition), 2006-07, Vol.368 (9532), p.287-298

2006

Volltextzugriff (PDF)

Issues in data monitoring and interim analysis of trials

Health technology assessment (Winchester, England), 2005-03, Vol.9 (7), p.1

2005

Volltextzugriff (PDF)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

HIV medicine, 2010-05, Vol.11 (5), p.334-344

2010

Volltextzugriff (PDF)

Determinants of survival following HIV-1 seroconversion after the introduction of HAART

The Lancet (British edition), 2003-10, Vol.362 (9392), p.1267-1274

2003

Volltextzugriff (PDF)

Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study

Statistics in medicine, 2001-12, Vol.20 (24), p.3715-3728

2001

Volltextzugriff (PDF)

The UK Clinical Research Network—building a world-class infrastructure for clinical research

Rheumatology (Oxford, England), 2008-06, Vol.47 (6), p.745-745

Darbyshire, J. H.

2008

Volltextzugriff (PDF)

Estimation and comparison of rates of change in longitudinal studies with informative drop-outs

Statistics in medicine, 1999-05, Vol.18 (10), p.1215-1233

1999

Volltextzugriff (PDF)

The UK Diabetes Research Network-an opportunity and a challenge

Diabetic medicine, 2007-01, Vol.24 (1), p.7-9

2007

Volltextzugriff (PDF)

Are healthcare workers in England and Wales at increased risk of tuberculosis?

BMJ, 1996-08, Vol.313 (7056), p.522-525

International edition, 1996

Volltextzugriff (PDF)

Tuberculosis in England and Wales in 1993 : results of a national survey

Thorax, 1997-12, Vol.52 (12), p.1060-1067

1997

Volltextzugriff (PDF)

A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome

Statistics in medicine, 2003-10, Vol.22 (20), p.3161-3175

2003

Volltextzugriff (PDF)

Randomization-based methods for correcting for treatment changes: examples from the Concorde trial

Statistics in medicine, 1999-10, Vol.18 (19), p.2617-2634

1999

Volltextzugriff (PDF)

Age as a determinant of survival in HIV infection

Journal of clinical epidemiology, 2001-12, Vol.54 (12), p.S16-S21

2001

Volltextzugriff (PDF)

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

Thorax, 1989-04, Vol.44 (4), p.280-288

1989

Volltextzugriff (PDF)

Geographical distribution of tuberculosis notifications in national surveys of England and Wales in 1988 and 1993: report of the Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group

Thorax, 1998-03, Vol.53 (3), p.176-181

1998

Volltextzugriff (PDF)

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals

The Lancet (British edition), 1996-08, Vol.348 (9023), p.283-291

Darbyshire, JH

1996

Volltextzugriff (PDF)

The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK Register of HIV seroconverters

AIDS (London), 1999-10, Vol.13 (14), p.1943-1951

1999

Volltextzugriff (PDF)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

The Lancet (British edition), 2010-01, Vol.375 (9709), p.123-131

2010

Volltextzugriff (PDF)

Impact of treatment changes on the interpretation of the Concorde trial

AIDS (London), 1997-07, Vol.11 (8), p.999-1006

1997

Volltextzugriff (PDF)

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection

The Lancet (British edition), 1994-04, Vol.343 (8902), p.871-881

1994

Volltextzugriff (PDF)

Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection

Journal of general virology, 1986-07, Vol.67 (7), p.1435-1442

1986

Volltextzugriff (PDF)

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial

BMJ, 2008-07, Vol.337 (7663), p.a257-a257

International edition, 2008

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Englisch
(353)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

PRION-1 scales analysis supports use of functional outcome measures in prion disease

Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

Issues in data monitoring and interim analysis of trials

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

Determinants of survival following HIV-1 seroconversion after the introduction of HAART

Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study

The UK Clinical Research Network—building a world-class infrastructure for clinical research

Estimation and comparison of rates of change in longitudinal studies with informative drop-outs

The UK Diabetes Research Network-an opportunity and a challenge

Are healthcare workers in England and Wales at increased risk of tuberculosis?

Tuberculosis in England and Wales in 1993 : results of a national survey

A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome

Randomization-based methods for correcting for treatment changes: examples from the Concorde trial

Age as a determinant of survival in HIV infection

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

Geographical distribution of tuberculosis notifications in national surveys of England and Wales in 1988 and 1993: report of the Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals

The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK Register of HIV seroconverters

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

Impact of treatment changes on the interpretation of the Concorde trial

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection

Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial

Suchergebnisse filtern